|
US7351729B2
(en)
*
|
2002-03-08 |
2008-04-01 |
Signal Pharmaceuticals, Llc |
JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
|
|
US7429609B2
(en)
*
|
2002-05-31 |
2008-09-30 |
Eisai R & D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
|
US20050070567A1
(en)
*
|
2002-08-12 |
2005-03-31 |
The Regents Of The University Of Michigan |
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
|
|
WO2004014222A2
(en)
*
|
2002-08-12 |
2004-02-19 |
The Regents Of The University Of Michigan |
Diagnosis and treatment of tuberous sclerosis
|
|
TW200523262A
(en)
*
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
JP2005089457A
(ja)
|
2003-09-03 |
2005-04-07 |
Yung Shin Pharmaceutical Industry Co Ltd |
骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
|
|
AU2004276341B2
(en)
*
|
2003-09-23 |
2011-04-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrrole derivatives as protein kinase inhibitors
|
|
EP1680401A2
(en)
*
|
2003-10-24 |
2006-07-19 |
Schering Aktiengesellschaft |
Indolinone derivatives and their use in treating disease-states such as cancer
|
|
AU2004293026B2
(en)
|
2003-11-21 |
2012-01-19 |
Array Biopharma Inc. |
AKT protein kinase inhibitors
|
|
US7473783B2
(en)
*
|
2003-12-17 |
2009-01-06 |
Sgx Pharmaceuticals, Inc. |
Bicyclic pyrazolo protein kinase modulators
|
|
FR2864084B1
(fr)
*
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
|
EP1714961B1
(en)
*
|
2004-02-12 |
2015-12-09 |
Mitsubishi Tanabe Pharma Corporation |
Indazole compound and pharmaceutical use thereof
|
|
US7592357B2
(en)
*
|
2004-02-20 |
2009-09-22 |
Smithkline Beecham Corporation |
Compounds
|
|
US7378532B2
(en)
|
2004-03-26 |
2008-05-27 |
Yung Shin Pharmaceutical Ind. Co., Ltd. |
Fused pyrazolyl compound
|
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
EP1778687A2
(en)
*
|
2004-07-27 |
2007-05-02 |
SGX Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
EP1854484A4
(en)
*
|
2005-02-16 |
2010-02-10 |
Astellas Pharma Inc |
REMEDY FOR PAIN CONTAINING INHIBITOR OF RHO-KINASE PROTEIN
|
|
US20070155738A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US7625890B2
(en)
|
2005-11-10 |
2009-12-01 |
Smithkline Beecham Corp. |
Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
|
|
WO2007058626A1
(en)
*
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
EP2385053B1
(en)
|
2005-11-17 |
2013-10-02 |
OSI Pharmaceuticals, Inc. |
Intermediates for the preparation of fused bicyclic mTOR inhibitors
|
|
EP2537849A3
(en)
|
2006-01-17 |
2013-04-03 |
Vertex Pharmaceuticals, Inc. |
Azaindoles useful as inhibitors of janus kinases
|
|
GB0606429D0
(en)
*
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
|
TW200808739A
(en)
|
2006-04-06 |
2008-02-16 |
Novartis Vaccines & Diagnostic |
Quinazolines for PDK1 inhibition
|
|
US20070286864A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Buck Elizabeth A |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
DK2049500T3
(da)
|
2006-07-06 |
2011-12-12 |
Array Biopharma Inc |
Cyclopenta [d]-pyrimidiner som AKT-proteinkinase-inhibitorer
|
|
WO2008006025A1
(en)
|
2006-07-06 |
2008-01-10 |
Array Biopharma Inc. |
Dihydrofuro pyrimidines as akt protein kinase inhibitors
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
SI2054418T1
(sl)
|
2006-07-06 |
2012-02-29 |
Array Biopharma Inc |
Dihidrotieno pirimidini kot AKT protein kinazni inhibitorji
|
|
DE102006033140A1
(de)
*
|
2006-07-18 |
2008-01-24 |
Merck Patent Gmbh |
Aminoindazolharnstoffderivate
|
|
US20080207671A1
(en)
*
|
2006-07-31 |
2008-08-28 |
The Regents Of The University Of Michigan |
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
|
|
CA2664335C
(en)
|
2006-09-20 |
2014-12-02 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
WO2008061109A2
(en)
*
|
2006-11-15 |
2008-05-22 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
WO2008070823A2
(en)
|
2006-12-07 |
2008-06-12 |
University Of South Florida |
Substrate-mimetic akt inhibitor
|
|
NZ577798A
(en)
|
2006-12-21 |
2012-04-27 |
Vertex Pharma |
5-cyano-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
WO2008089307A2
(en)
*
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
|
|
DE102007002717A1
(de)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
|
US20080188461A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Regents Of The University Of Michigan |
Compositions and methods for detecting, preventing and treating seizures and seizure related disorders
|
|
UY30892A1
(es)
*
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
JP2010522770A
(ja)
*
|
2007-03-29 |
2010-07-08 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
Ａｋｔ活性の阻害物質
|
|
DE102007022565A1
(de)
|
2007-05-14 |
2008-11-20 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
KR20150091196A
(ko)
*
|
2007-07-05 |
2015-08-07 |
어레이 바이오파마 인크. |
Ａｋｔ 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
|
|
CN101801955B
(zh)
|
2007-07-05 |
2013-05-08 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
US20090274698A1
(en)
*
|
2007-07-06 |
2009-11-05 |
Shripad Bhagwat |
Combination anti-cancer therapy
|
|
WO2009025477A1
(en)
*
|
2007-08-17 |
2009-02-26 |
Lg Life Sciences Ltd. |
Indole compounds as an inhibitor of cellular necrosis
|
|
UA110089C2
(uk)
|
2007-10-05 |
2015-11-25 |
Ак'Юсела Інк. |
Алкоксисполуки для лікування нейродегенеративних хвороб
|
|
CA2711699A1
(en)
|
2008-01-09 |
2009-07-16 |
Array Biopharma Inc. |
Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
KR101624752B1
(ko)
|
2008-01-09 |
2016-05-26 |
어레이 바이오파마 인크. |
Ａｋｔ 단백질 키나제 저해물질로써의 수산화된 피리미딜 시클로펜탄
|
|
WO2009145814A2
(en)
*
|
2008-03-10 |
2009-12-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
|
PL2283006T3
(pl)
|
2008-04-24 |
2015-08-31 |
F2G Ltd |
Pirolowe środki przeciwgrzybicze
|
|
US8158656B2
(en)
*
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
ES2445199T3
(es)
|
2008-06-05 |
2014-02-28 |
Glaxo Group Limited |
Derivados de benzpirazol como inhibidores de PI3-quinasas
|
|
ATE552255T1
(de)
*
|
2008-06-05 |
2012-04-15 |
Glaxo Group Ltd |
4-aminoindazole
|
|
JP5502858B2
(ja)
*
|
2008-06-05 |
2014-05-28 |
グラクソ グループ リミテッド |
Ｐｉ３キナーゼの阻害剤として有用な４−カルボキサミドインダゾール誘導体
|
|
ES2526966T3
(es)
|
2008-06-05 |
2015-01-19 |
Glaxo Group Limited |
Compuestos novedosos
|
|
WO2009158371A1
(en)
*
|
2008-06-26 |
2009-12-30 |
Smithklike Beecham Corporation |
Inhibitors of akt activity
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
WO2010017047A1
(en)
*
|
2008-08-05 |
2010-02-11 |
Merck & Co., Inc. |
Therapeutic compounds
|
|
DE102008038220A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
Oxadiazolderivate
|
|
DE102008038222A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
Indazol-5-carbonsäurehydrazid-derivate
|
|
DE102008038221A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
7-Azaindolderivate
|
|
JP5743897B2
(ja)
*
|
2008-11-20 |
2015-07-01 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ |
化合物
|
|
PE20120003A1
(es)
*
|
2009-01-30 |
2012-02-12 |
Glaxosmithkline Llc |
Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino
|
|
CN102317269B
(zh)
|
2009-02-11 |
2015-06-17 |
默克专利有限公司 |
新氨基氮杂杂环甲酰胺类
|
|
WO2010102958A1
(en)
|
2009-03-09 |
2010-09-16 |
Glaxo Group Limited |
4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
|
|
WO2010120854A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Glaxosmithkline Llc |
Chemical compounds
|
|
CA2759476C
(en)
|
2009-04-30 |
2018-10-09 |
Julie Nicole Hamblin |
Novel compounds
|
|
ES2553827T3
(es)
|
2009-05-01 |
2015-12-14 |
Aerie Pharmaceuticals, Inc. |
Inhibidores de mecanismo doble para el tratamiento de enfermedad
|
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
GEP20207129B
(en)
|
2009-06-17 |
2020-07-10 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
|
SG178273A1
(en)
|
2009-08-07 |
2012-03-29 |
Merck Patent Gmbh |
Novel azaheterocyclic compounds
|
|
EP2464647B1
(en)
|
2009-08-11 |
2016-09-21 |
Bristol-Myers Squibb Company |
Azaindazoles as btk kinase modulators and use thereof
|
|
US8487102B2
(en)
*
|
2010-04-20 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Pyrrazolopyridine compounds as dual NK1/NK3 receptor antagonists
|
|
WO2012016001A1
(en)
|
2010-07-29 |
2012-02-02 |
Merck Patent Gmbh |
Cyclic amine azaheterocyclic carboxamides
|
|
UA110113C2
(xx)
|
2010-07-29 |
2015-11-25 |
|
Біциклічні азагетероциклічні карбоксаміди
|
|
CN103201263A
(zh)
|
2010-09-08 |
2013-07-10 |
匹兹堡高等教育联邦体系大学 |
p53-Mdm2拮抗剂
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
WO2012065067A2
(en)
|
2010-11-12 |
2012-05-18 |
Georgetown University |
Immortalization of epithelial cells and methods of use
|
|
CA2818706C
(en)
|
2010-11-24 |
2019-07-23 |
Merck Patent Gmbh |
Quinazoline carboxamide azetidines
|
|
CN103492381A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
|
WO2012135759A1
(en)
|
2011-04-01 |
2012-10-04 |
Genentech, Inc. |
Combinations of akt inhibitor compounds and abiraterone, and methods of use
|
|
CN103841976A
(zh)
|
2011-04-01 |
2014-06-04 |
基因泰克公司 |
Akt和mek抑制剂化合物的组合及其使用方法
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
ES2644536T3
(es)
|
2011-09-12 |
2017-11-29 |
Merck Patent Gmbh |
Imidazol-aminas novedosas como moduladores de la actividad cinasa
|
|
JP6082011B2
(ja)
|
2011-09-12 |
2017-02-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
キナーゼ活性のモジュレーターとして使用するためのアミノピリミジン誘導体
|
|
CA2850394C
(en)
*
|
2011-10-12 |
2019-05-21 |
University Health Network |
Indazole compounds as kinase inhibitors and method of treating cancer with same
|
|
CN104169258B
(zh)
|
2011-12-22 |
2017-03-01 |
默克专利有限公司 |
用作激酶活性调节剂的新颖的杂环羧酰胺
|
|
WO2013104829A1
(en)
*
|
2012-01-13 |
2013-07-18 |
Medeia Therapeutics Ltd |
Novel arylamide derivatives having antiandrogenic properties
|
|
US8980934B2
(en)
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
WO2014056083A1
(en)
*
|
2012-10-12 |
2014-04-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
ES2620119T3
(es)
|
2012-11-16 |
2017-06-27 |
Merck Patent Gmbh |
Derivados heterocíclicos novedosos como moduladores de la actividad de quinasa
|
|
ES2807539T3
(es)
|
2012-11-16 |
2021-02-23 |
Merck Patent Gmbh |
Derivados de imidazol-piperidinilo como moduladores de la actividad de quinasa
|
|
ES2821102T3
(es)
|
2012-11-29 |
2021-04-23 |
Merck Patent Gmbh |
Derivados de azaquinazolincarboxamida
|
|
AR095202A1
(es)
|
2013-03-11 |
2015-09-30 |
Merck Patent Gmbh |
Heterociclos como moduladores de la actividad quinasa
|
|
HUE061618T2
(hu)
|
2013-03-15 |
2023-07-28 |
Aerie Pharmaceuticals Inc |
Vegyület szemrendellenességek kezelésére
|
|
KR20160104612A
(ko)
|
2013-07-26 |
2016-09-05 |
업데이트 파마 인코포레이트 |
비산트렌의 치료 효과 개선용 조성물
|
|
CN103570624B
(zh)
*
|
2013-08-06 |
2016-07-06 |
安徽世华化工有限公司 |
3-溴-5-硝基-1h-吲唑的合成工艺
|
|
US9629851B2
(en)
|
2013-09-20 |
2017-04-25 |
Stitching Het Nederlands Kanker Institut—Antoni Van Leeuwenhoek Ziekenhuis |
ROCK in combination with MAPK pathway
|
|
HRP20191525T1
(hr)
|
2013-11-13 |
2019-11-29 |
Vertex Pharma |
Inhibitori replikacije virusa influence
|
|
EP3421468B1
(en)
|
2013-11-13 |
2020-11-04 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
|
KR102410696B1
(ko)
|
2014-04-03 |
2022-06-17 |
메르크 파텐트 게엠베하 |
암 치료법의 조합
|
|
KR20170020527A
(ko)
|
2014-06-27 |
2017-02-22 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
배양된 포유동물 윤부 줄기세포, 이를 생성하는 방법, 및 이의 용도
|
|
KR101731624B1
(ko)
*
|
2014-07-01 |
2017-05-04 |
광주과학기술원 |
세포 리프로그래밍 유도용 조성물
|
|
LT3221308T
(lt)
|
2014-11-21 |
2018-12-27 |
F2G Limited |
Priešgrybeliniai agentai
|
|
DK3277799T3
(en)
|
2015-04-03 |
2020-12-14 |
Propagenix Inc |
Ex vivo proliferation af epithelceller
|
|
US10100285B2
(en)
|
2015-04-03 |
2018-10-16 |
Propagenix Inc. |
Ex vivo proliferation of epithelial cells
|
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
WO2017015152A1
(en)
|
2015-07-17 |
2017-01-26 |
Memorial Sloan-Kettering Cancer Center |
Combination therapy using pdk1 and pi3k inhibitors
|
|
EP3347450B1
(en)
|
2015-09-11 |
2021-03-17 |
Propagenix Inc. |
Ex vivo proliferation of epithelial cells
|
|
KR102579582B1
(ko)
|
2015-11-17 |
2023-09-15 |
에어리 파마슈티컬즈, 인코포레이티드 |
키나아제 억제제 및 이의 중간체의 제조 방법
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
GB201609222D0
(en)
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|
|
WO2018045091A1
(en)
|
2016-08-31 |
2018-03-08 |
Aerie Pharmaceuticals, Inc. |
Ophthalmic compositions
|
|
JP2020515583A
(ja)
|
2017-03-31 |
2020-05-28 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
アリールシクロプロピル−アミノ−イソキノリニルアミド化合物
|
|
RS65914B1
(sr)
*
|
2017-04-18 |
2024-10-31 |
Lilly Co Eli |
Fenil-2-hidroksi-acetilamino-2-metil-fenil jedinjenja
|
|
WO2018234354A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Grünenthal GmbH |
Novel substituted 3-indole and 3-indazole compounds as phosphodiesterase inhibitors
|
|
JP7206253B2
(ja)
*
|
2017-07-12 |
2023-01-17 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｒｏｃｋ阻害剤としてのフェニルアセトアミド
|
|
EA202090306A1
(ru)
*
|
2017-07-21 |
2020-06-25 |
Кадмон Корпорейшн, Ллк |
ИНГИБИТОРЫ Rho-АССОЦИИРОВАННОЙ, СОДЕРЖАЩЕЙ СУПЕРСПИРАЛЬ ПРОТЕИНКИНАЗЫ
|
|
EP3654972A4
(en)
*
|
2017-07-21 |
2021-03-17 |
Kadmon Corporation, LLC |
KINASE PROTEIN INHIBITORS CONTAINING A COIL COIL ASSOCIATED WITH RHO
|
|
SMT202400371T1
(it)
*
|
2018-02-16 |
2024-11-15 |
Constellation Pharmaceuticals Inc |
Inibitori di hat p300/cbp
|
|
US11414384B2
(en)
|
2018-02-16 |
2022-08-16 |
Constellation Pharmaceuticals, Inc. |
P300/CBP hat inhibitors
|
|
US20210189351A1
(en)
|
2018-08-20 |
2021-06-24 |
Propagenix Inc. |
Epithelial cell spheroids
|
|
WO2020047229A1
(en)
|
2018-08-29 |
2020-03-05 |
University Of Massachusetts |
Inhibition of protein kinases to treat friedreich ataxia
|
|
AU2019337703B2
(en)
|
2018-09-14 |
2023-02-02 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
UY38427A
(es)
|
2018-10-26 |
2020-05-29 |
Novartis Ag |
Métodos y composiciones para terapia con células oculares
|
|
US11819503B2
(en)
|
2019-04-23 |
2023-11-21 |
F2G Ltd |
Method of treating coccidioides infection
|
|
JP2022542421A
(ja)
*
|
2019-07-29 |
2022-10-03 |
コンステレーション・ファーマシューティカルズ・インコーポレイテッド |
神経障害の治療に使用するための化合物
|
|
JP2022552048A
(ja)
*
|
2019-08-21 |
2022-12-15 |
カルビスタ・ファーマシューティカルズ・リミテッド |
酵素阻害剤
|
|
PH12022550497A1
(en)
|
2019-08-29 |
2023-02-20 |
Hibercell Inc |
Perk inhibiting compounds
|
|
TWI777325B
(zh)
*
|
2019-12-31 |
2022-09-11 |
財團法人工業技術研究院 |
β-胺基酸衍生物、含其之激酶抑制劑與醫藥組成物以及其用途
|
|
CN111217834B
(zh)
*
|
2020-02-21 |
2021-10-26 |
维眸生物科技（上海）有限公司 |
Rock激酶抑制剂的硝基氧衍生物
|
|
JP2023522784A
(ja)
|
2020-04-27 |
2023-05-31 |
ノバルティス アーゲー |
眼細胞療法のための方法及び組成物
|
|
MX2023005520A
(es)
|
2020-11-16 |
2023-05-23 |
Merck Patent Gmbh |
Combinaciones de inhibidores de cinasa para tratamiento de cancer.
|
|
WO2023069949A1
(en)
|
2021-10-18 |
2023-04-27 |
Evia Life Sciences Inc. |
Compositions and methods of use thereof for treating liver fibrosis
|
|
CA3235862A1
(en)
|
2021-10-22 |
2023-04-27 |
Takahiro Ochiya |
Methods for making extracellular vesicles, and compositions and methods of use thereof
|
|
CN114605329B
(zh)
*
|
2022-03-28 |
2024-01-26 |
河南中医药大学 |
取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
|
|
CN116715634B
(zh)
*
|
2023-06-12 |
2025-11-21 |
北京新源医疗有限责任公司 |
一种化合物、药物组合物及在制备血管舒张药物中的应用
|
|
CN116891460A
(zh)
*
|
2023-07-12 |
2023-10-17 |
浙江大学 |
一种吲唑类衍生物或其药用盐及应用
|
|
WO2025088534A1
(en)
*
|
2023-10-27 |
2025-05-01 |
Dong-A St Co., Ltd. |
Bicyclic heterocycle compounds as tead inhibitor
|
|
CN117603084A
(zh)
*
|
2023-12-18 |
2024-02-27 |
江苏瑞思坦生物科技有限公司 |
肽酶神经溶素增强剂及其制备方法和应用
|